Treatment of Middle Cranial Fossa Arachnoid Cysts: A Systematic Review and Meta-Analysis
详细信息    查看全文
文摘
To review the literature and analyze the efficacy and safety of 3 surgical methods (neuroendoscopic fenestration, microsurgical fenestration, and cystoperitoneal shunting) for middle cranial fossa arachnoid cysts (MCFACs).

Methods

We searched MEDLINE, PubMed, and Cochrane Central electronic databases and collected studies of patients with MCFACs treated with 1 of 3 surgical methods. Eligible studies reported the rate of clinical symptoms improvement (RCSI), rate of cyst reduction (RCR), rate of total complications (RTC), rate of short-term complications (RSTC), rate of long-term complications (RLTC), and other parameters.

Results

Eighteen studies met the criteria. MCFACs were divided into 3 groups on the basis of surgical method: RCSI in group I (237 patients, neuroendoscopic fenestration) was 90% (95% confidence interval [CI]: 83%–95%); RCR: 76% (95% CI: 67%–84%); RTC: 28% (95% CI: 22%–34%); RSTC: 23% (95% CI: 17%–30%); and RLTC: 6% (95% CI: 3%–11%). RCSI in group II (144 patients, microsurgical fenestration) was 87% (95% CI: 75%–96%); RCR: 87% (95% CI: 70%–97%); RTC: 49% (95% CI: 30%–68%); RSTC: 44% (95% CI: 21%–68%); RLTC: 3% (95% CI: 0%–12%). RCSI in group III (93 patients, cystoperitoneal shunting) was 93% (95% CI: 66%–99%); RCR: 93% (95% CI: 66%–99%); RTC: 20% (95% CI: 5%–42%); RSTC: 10% (95% CI: 0%–31%); RLTC: 15% (95% CI: 9%–23%). RLTC differed significantly between the 3 groups (P = 0.005); RTC and RSTC between group I and group II (P = 0.002).

Conclusions

All 3 surgical methods are effective for MCFACs, but considering safety, neuroendoscopic fenestration may be the best initial procedure.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700